![]() Int J Geriatr Psychiatry 15:1021–1027īorson S, Scanlan JM, Watanabe J, Tu SP, Lessig M (2005) Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. Alzheimers Dement 11:718–726īorson S, Scanlan J, Brush M, Vitaliano P, Dokmak A (2000) The Mini-Cog: a cognitive‘vital signs’ measure for dementia screening in multi-lingual elderly. doi:10.1002/2īaumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. J Geriatr Psychiatry Neurol 28:145–155Īrevalo-Rodriguez I, Smailagic N, Roqué I, Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S (2015) Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Biol Psychiatry 23:271–284Īmodeo S, Mainland BJ, Herrmann N, Shulman KI (2015) The times they are a-changin’ clock drawing and prediction of dementia. Behavioral and psychological symptoms of dementiaĪlexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia.Improving understanding of the diversity in measures available to assist clinicians in differing care contexts is fundamental so that the best possible care and treatment plans can be implemented, and better support provided to next of kin and caregivers (both formal and informal caregivers). When selecting an instrument, clinicians must also consider possible population-based bias effects as a result of use in culturally and linguistically diverse populations or due to differences in educational attainment. Particular consideration must be given to factors such as the assessment setting (e.g., acute care versus residential care environment), the population for which a measure was developed, and the context in which the instrument was validated. ![]() This chapter provides a comprehensive overview and discussion of the key characteristics to consider when selecting a screening instrument to support accurate and timely assessment of cognitive changes and neuropsychiatric symptoms, both of which are core features of neurocognitive disorders. ![]() A number of instruments are available to clinicians to assess cognitive and neuropsychiatric features of neurocognitive disorders in older adults, from preclinical and prodromal stages through to more severe stages of dementia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |